in the effort. During the same period, Emergent sold the government nearly $1 billion in anthrax vaccines, financial disclosures show." Related legislation Section 403 of the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (H.R. 307; 113th Congress) reauthorized the Strategic National Stockpile for FY2014-FY2018. It required the Secretary of Health and Human Services to: submit to the appropriate congressional committees, to the extent that the disclosure of such information does not compromise national security, the annual review of the contents of the Stockpile; and review and revise the contents of the Stockpile to ensure that the potential depletion of countermeasures currently in the Stockpile is identified and appropriately addressed, including through necessary replenishment. See also References External links Official site Biological warfare Centers for Disease Control and Prevention Strategic reserves of the United States Trump administration controversies